Literature DB >> 9482660

Endothelin-1 is a potent survival factor for c-Myc-dependent apoptosis.

M Shichiri1, J M Sedivy, F Marumo, Y Hirata.   

Abstract

Many vertebrate cells are resistant to apoptotic stimuli, whose variety and the mechanisms involved are not fully understood. Endothelin-1 is an endothelium-derived vasoactive peptide that mediates many physiological functions, such as vasoconstriction and cell proliferation. Deregulated expression of c-Myc induces apoptosis in serum-deprived fibroblasts. Using a panel of isogenic fibroblast cell lines with differential c-myc expression levels, we demonstrate that low doses of endothelin-1 protect fibroblasts against serum deprivation-induced apoptosis, which occurs through a c-Myc-dependent process. The endothelin-1-induced cell survival was mediated by the ET(A) receptor and was not linked to the ability of endothelin-1 to induce cell proliferation. The survival function of endothelin-1 was abrogated by inhibiting the mitogen-activated protein kinase pathway. These results demonstrate a hitherto unappreciated role of endothelin-1 as a potent survival factor for c-Myc-dependent apoptosis, a process mediated by the ET(A) receptor and the mitogen-activated protein kinase pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482660     DOI: 10.1210/mend.12.2.0064

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  14 in total

1.  Involvement of nuclear factor-kappaB in endothelin-A-receptor-induced proliferation and inhibition of apoptosis.

Authors:  M Mangelus; R Galron; Z Naor; M Sokolovsky
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

2.  Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1.

Authors:  Feng Dong; Xiaochun Zhang; Loren E Wold; Qun Ren; Zhaojie Zhang; Jun Ren
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

Review 3.  Endothelium-derived ET-1 and the development of renal injury.

Authors:  Carmen De Miguel; David M Pollock; Jennifer S Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-05-20       Impact factor: 3.619

4.  5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways.

Authors:  C G Nebigil; J M Launay; P Hickel; C Tournois; L Maroteaux
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Modulation of human colon tumor-stromal interactions by the endothelin system.

Authors:  G Egidy; L Juillerat-Jeanneret; J F Jeannin; P Korth; F T Bosman; F Pinet
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

6.  Endothelin-Mediated Changes in Gene Expression in Isolated Purified Rat Retinal Ganglion Cells.

Authors:  Shaoqing He; Yong H Park; Thomas Yorio; Raghu R Krishnamoorthy
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09-01       Impact factor: 4.799

7.  Endothelin Confers Protection against High Glucose-Induced Neurotoxicity via Alleviation of Oxidative Stress.

Authors:  Mohamed A Fouda; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2017-02-08       Impact factor: 4.030

8.  The endothelin system in Morris hepatoma-7777: an endothelin receptor antagonist inhibits growth in vitro and in vivo.

Authors:  Thiemo Pfab; Gisela Stoltenburg-Didinger; Christoph Trautner; Michael Godes; Christian Bauer; Berthold Hocher
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

9.  Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells.

Authors:  L Peduto Eberl; R Bovey; L Juillerat-Jeanneret
Journal:  Br J Cancer       Date:  2003-03-10       Impact factor: 7.640

Review 10.  Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion.

Authors:  Gjumrakch Aliev; Mark E Obrenovich; Shams Tabrez; Nasimudeen R Jabir; V Prakash Reddy; Yi Li; Geoffrey Burnstock; Ramon Cacabelos; Mohammad Amjad Kamal
Journal:  Oxid Med Cell Longev       Date:  2013-04-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.